Caring for Patients Receiving CAR T-Cell Therapy With Joshua Sasine, MD, PhD

In this interview with Oncology Data Advisor, Dr. Joshua Sasine, Hematologist-Oncologist at Cedars-Sinai Medical Center, discusses the factors that make patients suitable candidates for chimeric antigen receptor (CAR) T-cell therapy, strategies to minimize the unique toxicities associated with these treatments, and the future of the use of CAR T-cell therapy in the outpatient setting.  

Continue reading

Copyright © 2022 Oncology Data Advisor. All rights reserved.